Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against Omicron Variant
Synopsis : Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active…
Synopsis : Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active…
Summary – Pfizer says the protection provided by two doses of its anti-COVID-19 vaccine against previous strains will match that provided by…
The European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
Summary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…